The difference of severity of tumor induction between the two myc oncogenes are likely due to the level of induced expression as we observed an increasing severity of tumor progression from both mycAG and mycBG transgenic lines with increased mifepristone inducer, although the possibility that myca is more potent in ongogenesis than mycb could not be completely ruled out. This evidence concerns the gene MYC and neoplasm.